TY - JOUR AU - Mozaffarian, D. AU - Benjamin, E. J. AU - Go, A. S. AU - Arnett, D. K. AU - Blaha, M. J. AU - Cushman, M. PY - 2015 DA - 2015// TI - Heart disease and stroke statistics—2015 update: a report from the American Heart Association JO - Circulation VL - 131 UR - https://doi.org/10.1161/CIR.0000000000000152 DO - 10.1161/CIR.0000000000000152 ID - Mozaffarian2015 ER - TY - JOUR AU - Kannel, W. B. AU - Feinleib, M. PY - 1972 DA - 1972// TI - Natural history of angina pectoris in the Framingham study: prognosis and survival JO - Am J Cardiol VL - 29 UR - https://doi.org/10.1016/0002-9149(72)90624-8 DO - 10.1016/0002-9149(72)90624-8 ID - Kannel1972 ER - TY - JOUR AU - Ross, R. PY - 1999 DA - 1999// TI - Atherosclerosis—an inflammatory disease JO - N Engl J Med VL - 340 UR - https://doi.org/10.1056/NEJM199901143400207 DO - 10.1056/NEJM199901143400207 ID - Ross1999 ER - TY - JOUR AU - Libby, P. PY - 2005 DA - 2005// TI - Act local, act global: inflammation and the multiplicity of “vulnerable” coronary plaques JO - J Am Coll Cardiol VL - 45 UR - https://doi.org/10.1016/j.jacc.2005.02.058 DO - 10.1016/j.jacc.2005.02.058 ID - Libby2005 ER - TY - JOUR AU - Macphee, C. H. AU - Nelson, J. AU - Zalewski, A. PY - 2006 DA - 2006// TI - Role of lipoprotein-associated phospholipase A2 in atherosclerosis and its potential as a therapeutic target JO - Curr Opin Pharmacol VL - 6 UR - https://doi.org/10.1016/j.coph.2005.11.008 DO - 10.1016/j.coph.2005.11.008 ID - Macphee2006 ER - TY - JOUR AU - Hakkinen, T. AU - Luoma, J. S. AU - Hiltunen, M. O. AU - Macphee, C. H. AU - Milliner, K. J. AU - Patel, L. PY - 1999 DA - 1999// TI - Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, is expressed by macrophages in human and rabbit atherosclerotic lesions JO - Arterioscler Thromb Vasc Biol VL - 19 UR - https://doi.org/10.1161/01.ATV.19.12.2909 DO - 10.1161/01.ATV.19.12.2909 ID - Hakkinen1999 ER - TY - JOUR AU - Kolodgie, F. D. AU - Burke, A. P. AU - Skorija, K. S. AU - Ladich, E. AU - Kutys, R. AU - Makuria, A. T. PY - 2006 DA - 2006// TI - Lipoprotein-associated phospholipase A2 protein expression in the natural progression of human coronary atherosclerosis JO - Arterioscler Thromb Vasc Biol VL - 26 UR - https://doi.org/10.1161/01.ATV.0000244681.72738.bc DO - 10.1161/01.ATV.0000244681.72738.bc ID - Kolodgie2006 ER - TY - JOUR AU - Herrmann, J. AU - Mannheim, D. AU - Wohlert, C. AU - Versari, D. AU - Meyer, F. B. AU - McConnell, J. P. PY - 2009 DA - 2009// TI - Expression of lipoprotein-associated phospholipase A2 in carotid artery plaques predicts long-term cardiac outcome JO - Eur Heart J VL - 30 UR - https://doi.org/10.1093/eurheartj/ehp309 DO - 10.1093/eurheartj/ehp309 ID - Herrmann2009 ER - TY - JOUR AU - Mallat, Z. AU - Lambeau, G. AU - Tedgui, A. PY - 2010 DA - 2010// TI - Lipoprotein-associated and secreted phospholipases A2 in cardiovascular disease: roles as biological effectors and biomarkers JO - Circulation VL - 122 UR - https://doi.org/10.1161/CIRCULATIONAHA.110.936393 DO - 10.1161/CIRCULATIONAHA.110.936393 ID - Mallat2010 ER - TY - JOUR AU - Koenig, W. AU - Twardella, D. AU - Brenner, H. AU - Rothenbacher, D. PY - 2006 DA - 2006// TI - Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress JO - Arterioscler Thromb Vasc Biol VL - 26 UR - https://doi.org/10.1161/01.ATV.0000222983.73369.c8 DO - 10.1161/01.ATV.0000222983.73369.c8 ID - Koenig2006 ER - TY - JOUR AU - Brilakis, E. S. AU - McConnell, J. P. AU - Lennon, R. J. AU - Elesber, A. A. AU - Meyer, J. G. AU - Berger, P. B. PY - 2005 DA - 2005// TI - Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up JO - Eur Heart J VL - 26 UR - https://doi.org/10.1093/eurheartj/ehi010 DO - 10.1093/eurheartj/ehi010 ID - Brilakis2005 ER - TY - JOUR AU - Sabatine, M. S. AU - Morrow, D. A. AU - O’Donoghue, M. AU - Jablonksi, K. A. AU - Rice, M. M. AU - Solomon, S. PY - 2007 DA - 2007// TI - Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease JO - Arterioscler Thromb Vasc Biol VL - 27 UR - https://doi.org/10.1161/ATVBAHA.107.151670 DO - 10.1161/ATVBAHA.107.151670 ID - Sabatine2007 ER - TY - JOUR AU - Rosenson, R. S. AU - Stafforini, D. M. PY - 2012 DA - 2012// TI - Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2 JO - J Lipid Res VL - 53 UR - https://doi.org/10.1194/jlr.R024190 DO - 10.1194/jlr.R024190 ID - Rosenson2012 ER - TY - JOUR AU - Cheng, T. O. PY - 2007 DA - 2007// TI - Cardiovascular effects of Danshen JO - Int J Cardiol VL - 121 UR - https://doi.org/10.1016/j.ijcard.2007.01.004 DO - 10.1016/j.ijcard.2007.01.004 ID - Cheng2007 ER - TY - JOUR AU - Zhou, L. AU - Zuo, Z. AU - Chow, M. S. PY - 2005 DA - 2005// TI - Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use JO - J Clin Pharmacol VL - 45 UR - https://doi.org/10.1177/0091270005282630 DO - 10.1177/0091270005282630 ID - Zhou2005 ER - TY - JOUR AU - Stumpf, C. AU - Fan, Q. AU - Hintermann, C. AU - Raaz, D. AU - Kurfurst, I. AU - Losert, S. PY - 2013 DA - 2013// TI - Anti-inflammatory effects of danshen on human vascular endothelial cells in culture JO - Am J Chin Med VL - 41 UR - https://doi.org/10.1142/S0192415X13500729 DO - 10.1142/S0192415X13500729 ID - Stumpf2013 ER - TY - JOUR AU - Luo, J. AU - Xu, H. AU - Chen, K. PY - 2013 DA - 2013// TI - Systematic review of compound Danshen dropping pill: a Chinese patent medicine for acute myocardial infarction JO - Evid Based Complement Altern Med VL - 2013 ID - Luo2013 ER - TY - JOUR AU - Mao, C. AU - Chung, V. C. AU - Yuan, J. Q. AU - Yu, Y. Y. AU - Yang, Z. Y. AU - Wu, X. Y. PY - 2013 DA - 2013// TI - Evaluation of the add-on effect of Chinese patent medicine for patients with stable or unstable angina: a systematic review and meta-analysis JO - Evid Based Complement Altern Med VL - 2013 UR - https://doi.org/10.1155/2013/673193 DO - 10.1155/2013/673193 ID - Mao2013 ER - TY - JOUR AU - Chan, A. W. AU - Tetzlaff, J. M. AU - Altman, D. G. AU - Laupacis, A. AU - Gotzsche, P. C. AU - Krleza-Jeric, K. PY - 2013 DA - 2013// TI - SPIRIT 2013 statement: defining standard protocol items for clinical trials JO - Ann Intern Med VL - 158 UR - https://doi.org/10.7326/0003-4819-158-3-201302050-00583 DO - 10.7326/0003-4819-158-3-201302050-00583 ID - Chan2013 ER - TY - JOUR AU - Ridker, P. M. AU - MacFadyen, J. G. AU - Wolfert, R. L. AU - Koenig, W. PY - 2012 DA - 2012// TI - Relationship of lipoprotein-associated phospholipase A2 mass and activity with incident vascular events among primary prevention patients allocated to placebo or to statin therapy: an analysis from the JUPITER trial JO - Clin Chem VL - 58 UR - https://doi.org/10.1373/clinchem.2011.180281 DO - 10.1373/clinchem.2011.180281 ID - Ridker2012 ER - TY - JOUR AU - Ryu, S. K. AU - Mallat, Z. AU - Benessiano, J. AU - Tedgui, A. AU - Olsson, A. G. AU - Bao, W. PY - 2012 DA - 2012// TI - Phospholipase A2 enzymes, high-dose atorvastatin, and prediction of ischemic events after acute coronary syndromes JO - Circulation VL - 125 UR - https://doi.org/10.1161/CIRCULATIONAHA.111.063487 DO - 10.1161/CIRCULATIONAHA.111.063487 ID - Ryu2012 ER - TY - JOUR AU - Mohler, E. R. AU - Ballantyne, C. M. AU - Davidson, M. H. AU - Hanefeld, M. AU - Ruilope, L. M. AU - Johnson, J. L. PY - 2008 DA - 2008// TI - The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study JO - J Am Coll Cardiol VL - 51 UR - https://doi.org/10.1016/j.jacc.2007.11.079 DO - 10.1016/j.jacc.2007.11.079 ID - Mohler2008 ER - TY - JOUR AU - Sakpal, T. V. PY - 2010 DA - 2010// TI - Sample size estimation in clinical trial JO - Perspect Clin Res VL - 1 ID - Sakpal2010 ER - TY - STD TI - Chinese Society of Cardiology; Chinese Medical Association; Editorial Board, Chinese Journal of Cardiology. Guideline for diagnosis and treatment of patients with chronic stable angina [in Chinese]. Zhonghua Xin Xue Guan Bing Za Zhi. 2007;35(3):195–206. ID - ref24 ER - TY - JOUR AU - Lin, T. H. AU - Hsieh, C. L. PY - 2010 DA - 2010// TI - Pharmacological effects of Salvia miltiorrhiza (Danshen) on cerebral infarction JO - Chin Med VL - 5 UR - https://doi.org/10.1186/1749-8546-5-22 DO - 10.1186/1749-8546-5-22 ID - Lin2010 ER - TY - JOUR AU - Woo, K. S. AU - Yip, T. W. AU - Chook, P. AU - Kwong, S. K. AU - Szeto, C. C. AU - Li, J. K. PY - 2013 DA - 2013// TI - Cardiovascular protective effects of adjunctive alternative medicine (Salvia miltiorrhiza and Pueraria lobata) in high-risk hypertension JO - Evid Based Complement Altern Med VL - 2013 ID - Woo2013 ER - TY - JOUR AU - Tam, W. Y. AU - Chook, P. AU - Qiao, M. AU - Chan, L. T. AU - Chan, T. Y. AU - Poon, Y. K. PY - 2009 DA - 2009// TI - The efficacy and tolerability of adjunctive alternative herbal medicine (Salvia miltiorrhiza and Pueraria lobata) on vascular function and structure in coronary patients JO - J Altern Complement Med VL - 15 UR - https://doi.org/10.1089/acm.2008.0400 DO - 10.1089/acm.2008.0400 ID - Tam2009 ER - TY - JOUR AU - Chen, Z. AU - Xu, H. PY - 2014 DA - 2014// TI - Anti-inflammatory and immunomodulatory mechanism of tanshinone IIA for atherosclerosis JO - Evid Based Complement Altern Med VL - 2014 ID - Chen2014 ER - TY - JOUR AU - Meng, C. AU - Zhuo, X. Q. AU - Xu, G. H. AU - Liu, J. L. PY - 2014 DA - 2014// TI - Protection of salvianolate against atherosclerosis via regulating the inflammation in rats JO - J Huazhong Univ Sci Technolog Med Sci VL - 34 UR - https://doi.org/10.1007/s11596-014-1331-z DO - 10.1007/s11596-014-1331-z ID - Meng2014 ER - TY - JOUR AU - Poppel, P. C. AU - Breedveld, P. AU - Abbink, E. J. AU - Roelofs, H. AU - Heerde, W. AU - Smits, P. PY - 2015 DA - 2015// TI - Salvia miltiorrhiza root water-extract (Danshen) has no beneficial effect on cardiovascular risk factors: a randomized double-blind cross-over trial JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0128695 DO - 10.1371/journal.pone.0128695 ID - Poppel2015 ER - TY - JOUR AU - Libby, P. AU - Hansson, G. K. PY - 2015 DA - 2015// TI - Inflammation and immunity in diseases of the arterial tree: players and layers JO - Circ Res VL - 116 UR - https://doi.org/10.1161/CIRCRESAHA.116.301313 DO - 10.1161/CIRCRESAHA.116.301313 ID - Libby2015 ER - TY - JOUR AU - Talmud, P. J. AU - Holmes, M. V. PY - 2015 DA - 2015// TI - Deciphering the causal role of s PLA2s and Lp-PLA2 in coronary heart disease JO - Arterioscler Thromb Vasc Biol VL - 35 UR - https://doi.org/10.1161/ATVBAHA.115.305234 DO - 10.1161/ATVBAHA.115.305234 ID - Talmud2015 ER - TY - JOUR AU - Cai, A. AU - Zheng, D. AU - Qiu, R. AU - Mai, W. AU - Zhou, Y. PY - 2013 DA - 2013// TI - Lipoprotein-associated phospholipase A2 (Lp-PLA2): a novel and promising biomarker for cardiovascular risks assessment JO - Dis Markers VL - 34 UR - https://doi.org/10.1155/2013/432136 DO - 10.1155/2013/432136 ID - Cai2013 ER - TY - JOUR AU - Wilensky, R. L. AU - Macphee, C. H. PY - 2009 DA - 2009// TI - Lipoprotein-associated phospholipase A2 and atherosclerosis JO - Curr Opin Lipidol VL - 20 UR - https://doi.org/10.1097/MOL.0b013e3283307c16 DO - 10.1097/MOL.0b013e3283307c16 ID - Wilensky2009 ER -